This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: City University of Hong Kong, The University of Hong Kong. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Qi Xu: Innovator in Medical and Energy Systems
Introduction
Qi Xu is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the fields of medicine and energy systems. With a total of 2 patents, his work focuses on innovative methods for treating infections and detecting anomalies in energy systems.
Latest Patents
Qi Xu's latest patents include "Methods for treating hypervirulent infection" and "Anomaly detection in energy systems." The first patent outlines a method for treating hypervirulent (hvKp) infections by co-administering a therapeutically effective amount of an antibiotic along with a non-steroidal anti-inflammatory drug or a signal transducer and activator of transcription 1 inhibitor. The second patent describes a method and system for detecting anomalies in energy systems using non-contact sensing based on electric and magnetic fields. This method involves filtering electric and magnetic field signals to remove noise, extracting features, and performing density-based spatial clustering to identify anomalies.
Career Highlights
Qi Xu has worked at notable institutions such as The University of Hong Kong and City University of Hong Kong. His experience in these prestigious universities has allowed him to develop and refine his innovative ideas.
Collaborations
Some of his notable coworkers include Wing Tat Pong and Ke Zhu. Their collaboration has contributed to the advancement of research in their respective fields.
Conclusion
Qi Xu is an influential inventor whose work in medical treatments and energy systems showcases his innovative spirit. His patents reflect a commitment to addressing critical challenges in health and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

